OPTZF yields 42.33% · PFE yields 6.13%● Live data
📍 OPTZF pulled ahead of the other in Year 1
Combined, OPTZF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of OPTZF + PFE for your $10,000?
OptiCept Technologies AB (publ) develops a technology that controls and applies electrical pulses to optimize various biological processes in Sweden and internationally. The company offers foodtech products, such as juiceCEPT, a c machine; juiceCEPT+, an application for the juice industry; oliveCEPT that deploys a pre-treatment to olive paste in extra virgin olive oil production (EVOO) for better quality of the product and increases extracted EVOO yield; wineCEPT, a technology for the treatment of targets cell membranes in biomass; and dryCEPT to reduce drying time, enhanced flavor, and vivid color on the final dried products. It also provides planttech products, including OptiBoost for cut flowers and OptiBoost for cuttings. The company's products are used for applications in beer, dairy, flowers, food oils, juice, plant milk, and wine. The company was formerly known as OptiFreeze AB (publ) and changed its name to OptiCept Technologies AB (publ) in July 2021. OptiCept Technologies AB (publ) was incorporated in 2011 and is headquartered in Lund, Sweden.
Full OPTZF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.